Postdoctoral Researcher in Influenza Virology and Innate Immunity; m​/f​/d

Background:
The research group of Dr Kevin Ciminski investigates molecular virus-host interactions that determine the zoonotic and pandemic potential of influenza A viruses. Within the ERC Starting Grant project FLU-ARMOR, we will examine how zoonotic influenza viruses overcome MxA-mediated human innate immune restriction and acquire traits associated with human adaptation. By combining experimental analyses of viral immune-evasion mechanisms with AI-assisted surveillance approaches, the project aims to identify molecular risk signatures and establish a mechanistically informed framework for the early assessment of emerging influenza viruses and contribute to pandemic preparedness.

• a central scientific role in the newly established ERC Starting Grant project FLU-ARMOR
• the opportunity to develop an independent research profile and supervise junior researchers
• access to state-of-the-art BSL-3 laboratories, imaging, sequencing and animal facilities
• close interaction with national and international collaborators in virology, immunology and computational biology
• structured mentoring and support for publications, conference participation, and future fellowship applications
• a full-time position (38.5h/week) for five years, with remuneration according to TV-L E13
• an attractive research and living environment in Freiburg, a vibrant university city located at the edge of the Black Forest

• PhD in virology, infection biology, or related fields
• proven experience in molecular virology, virus-host interactions or innate immunity
• independent, highly motivated researcher eager to adapt to novel technologies and methodologies
• demonstrated collaborative skills and commitment to scientific excellence
• excellent written and spoken English (CEFR level C1 or equivalent)
• strong publication record appropriate to the applicant's career stage

• experience with influenza viruses or other respiratory viruses
• experience with reverse genetics and cell-based infection models
• experience working under BSL-3 conditionsexperience working with mouse models (EU function A,D - formerly FELASA
  
  B)

Final date to receive applications:
October 25, 2026.

Starting date:
January, 2027.

Dr. Kevin Ciminski
Institute of Virology Freiburg
kevin.ci